Endolysin LysEF-P10 shows potential as an alternative treatment strategy for multidrug-resistant Enterococcus faecalis infections

Scientific Reports

Volumn 7, Issue 1, 2017, Pages

  Cheng, Mengjun ^a   Zhang, Yufeng ^a   Li, Xinwei ^a   Liang, Jiaming ^a   Hu, Liyuan ^a   Gong, Pengjuan ^a   Zhang, Lei ^a   Cai, Ruopeng ^a   Zhang, Hao ^a   Ge, Jinli ^a   Ji, Yalu ^a   Guo, Zhimin ^b   Feng, Xin ^a   Sun, Changjiang ^a   Yang, Yongjun ^a   Lei, Liancheng ^a   Han, Wenyu ^a,c   Gu, Jingmin ^a,c  

^a JILIN UNIVERSITY   (China)

^b THE FIRST HOSPITAL OF JILIN UNIVERSITY   (China)

^c YANGZHOU UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOSIDASE; VIRAL PROTEIN;

ANIMAL; BACTERIOPHAGE; BINDING SITE; CHEMISTRY; DISEASE MODEL; DRUG EFFECT; ENTEROCOCCUS FAECALIS; ENZYMOLOGY; FEMALE; GENETICS; GRAM POSITIVE INFECTION; HUMAN; ISOLATION AND PURIFICATION; MICROBIAL SENSITIVITY TEST; MICROBIAL VIABILITY; MOLECULAR MODEL; MOUSE; MULTIDRUG RESISTANCE; MUTATION; PROTEIN CONFORMATION; SEQUENCE HOMOLOGY; VIROLOGY;

ANIMALS; BACTERIOPHAGES; BINDING SITES; DISEASE MODELS, ANIMAL; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ENTEROCOCCUS FAECALIS; FEMALE; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; MICE; MICROBIAL SENSITIVITY TESTS; MICROBIAL VIABILITY; MODELS, MOLECULAR; MUTATION; N-GLYCOSYL HYDROLASES; PROTEIN CONFORMATION; SEQUENCE HOMOLOGY, AMINO ACID; VIRAL PROTEINS;

EID: 85028672842     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/s41598-017-10755-7     Document Type: Article

References (64)

1. Wittebole, X., De Roock, S. & Opal, S. M. A historical overview of bacteriophage therapy as an alternative to antibiotics for the treatment of bacterial pathogens. Virulence 5, 226-235, doi: 10.4161/viru.25991 (2014).
2. Hermoso, J. A., Garcia, J. L. & Garcia, P. Taking aim on bacterial pathogens: from phage therapy to enzybiotics. Curr Opin Microbiol 10, 461-472, doi:S1369-5274(07)00102-6 (2007).
3. Witzenrath, M. et al. Systemic use of the endolysin Cpl-1 rescues mice with fatal pneumococcal pneumonia. Critical care medicine 37, 642-649, doi: 10.1097/CCM.0b013e31819586a6 (2009).
4. Loeffler, J. M., Nelson, D. & Fischetti, V. A. Rapid killing of Streptococcus pneumoniae with a bacteriophage cell wall hydrolase. Science 294, 2170-2172, doi: 10.1126/science.1066869 (2001).
5. Koch, S., Hufnagel, M., Theilacker, C. & Huebner, J. Enterococcal infections: host response, therapeutic, and prophylactic possibilities. Vaccine 22, 822-830, doi: 10.1016/j.vaccine.2003.11.027 (2004).
6. Cetinkaya, Y., Falk, P. & Mayhall, C. G. Vancomycin-resistant enterococci. Clinical microbiology reviews 13, 686-707 (2000).
7. Jett, B. D., Huycke, M. M. & Gilmore, M. S. Virulence of enterococci. Clinical microbiology reviews 7, 462-478 (1994).
8. Murray, B. E. The life and times of the Enterococcus. Clinical microbiology reviews 3, 46-65 (1990).
9. Emori, T. G. & Gaynes, R. P. An overview of nosocomial infections, including the role of the microbiology laboratory. Clinical microbiology reviews 6, 428-442 (1993).
10. Gilmore, M. S., Lebreton, F. & van Schaik, W. Genomic transition of enterococci from gut commensals to leading causes of multidrug-resistant hospital infection in the antibiotic era. Current opinion in microbiology 16, 10-16, doi: 10.1016/j.mib.2013.01.006 (2013).
11. Sava, I. G., Heikens, E. & Huebner, J. Pathogenesis and immunity in enterococcal infections. Clinical microbiology and infection: the official publication of the European Society of Clinical Microbiology and Infectious Diseases 16, 533-540, doi: 10.1111/j.1469-0691.2010.03213.x (2010).
12. Hammerum, A. M. Enterococci of animal origin and their significance for public health. Clinical microbiology and infection: the official publication of the European Society of Clinical Microbiology and Infectious Diseases 18, 619-625, doi: 10.1111/j.1469-0691.2012.03829.x (2012).
13. Salyers, A. A., Gupta, A. & Wang, Y. Human intestinal bacteria as reservoirs for antibiotic resistance genes. Trends in microbiology 12, 412-416, doi: 10.1016/j.tim.2004.07.004 (2004).
14. Courvalin, P. Vancomycin resistance in gram-positive cocci. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America 42(Suppl 1), S25-34, doi: 10.1086/491711 (2006).
15. Theuretzbacher, U. Accelerating resistance, inadequate antibacterial drug pipelines and international responses. International journal of antimicrobial agents 39, 295-299, doi: 10.1016/j.ijantimicag.2011.12.006 (2012).
16. Zhang, W. et al. Characterization of Enterococcus faecalis phage IME-EF1 and its endolysin. PloS one 8, e80435, doi: 10.1371/journal.pone.0080435 (2013).
17. Lu, J. Z., Fujiwara, T., Komatsuzawa, H., Sugai, M. & Sakon, J. Cell wall-targeting domain of glycylglycine endopeptidase distinguishes among peptidoglycan cross-bridges. The Journal of biological chemistry 281, 549-558, doi: 10.1074/jbc.M509691200 (2006).
18. Cheng, M. et al. The Bacteriophage EF-P29 Efficiently Protects against Lethal Vancomycin-Resistant Enterococcus faecalis and Alleviates Gut Microbiota Imbalance in a Murine Bacteremia Model. Front Microbiol 8, 837, doi: 10.3389/fmicb.2017.00837 (2017).
19. Jingmin G, Y. F. et al. Structural and Biochemical Characterization Reveals LysGH15 as an Unprecedented "EF-Hand-Like" Calcium-binding phage lysin. PLOS Pathogens 10, e1004109, doi: 10.1371/journal.ppat.1004109.g001 (2014).
20. Uchiyama, J. et al. Characterization of lytic enzyme open reading frame 9 (ORF9) derived from Enterococcus faecalis bacteriophage phiEF24C. Applied and environmental microbiology 77, 580-585, doi: 10.1128/AEM.01540-10 (2011).
21. Yoong, P., Schuch, R., Nelson, D. & Fischetti, V. A. Identification of a broadly active phage lytic enzyme with lethal activity against antibiotic-resistant Enterococcus faecalis and Enterococcus faecium. Journal of bacteriology 186, 4808-4812, doi: 10.1128/JB.186.14.4808-4812.2004 (2004).
22. Son, J. S. et al. Complete genome sequence of a newly isolated lytic bacteriophage, EFAP-1 of Enterococcus faecalis, and antibacterial activity of its endolysin EFAL-1. Journal of applied microbiology 108, 1769-1779, doi: 10.1111/j.1365-2672.2009.04576.x (2010).
23. Proenca, D. et al. Phage endolysins with broad antimicrobial activity against Enterococcus faecalis clinical strains. Microbial drug resistance 18, 322-332, doi: 10.1089/mdr.2012.0024 (2012).
24. Fischetti, V. A. Bacteriophage endolysins: a novel anti-infective to control Gram-positive pathogens. International journal of medical microbiology: IJMM 300, 357-362, doi: 10.1016/j.ijmm.2010.04.002 (2010).
25. Young, R. Phage lysis: do we have the hole story yet? Current opinion in microbiology 16, 790-797, doi: 10.1016/j.mib.2013.08.008 (2013).
26. Zhou, Y. et al. Prediction of EF-hand calcium-binding proteins and analysis of bacterial EF-hand proteins. Proteins 65, 643-655, doi: 10.1002/prot.21139 (2006).
27. Pai, C. H. et al. Dual binding sites for translocation catalysis by Escherichia coli glutathionylspermidine synthetase. The EMBO journal 25, 5970-5982, doi: 10.1038/sj.emboj.7601440 (2006).
28. Fischetti, V. A. Bacteriophage lytic enzymes: novel anti-infectives. Trends Microbiol 13, 491-496, doi:S0966-842X(05)00225-8 (2005).
29. Garcia, E. et al. Molecular evolution of lytic enzymes of Streptococcus pneumoniae and its bacteriophages. Proc Natl Acad Sci USA 85, 914-918 (1988).
30. McLaughlin, S., Wang, J., Gambhir, A. & Murray, D. PIP(2) and proteins: interactions, organization, and information flow. Annu Rev Biophys Biomol Struct 31, 151-175, doi: 10.1146/annurev.biophys.31.082901.134259 (2002).
31. Pastagia, M. et al. A novel chimeric lysin shows superiority to mupirocin for skin decolonization of methicillin-resistant and -sensitive Staphylococcus aureus strains. Antimicrobial agents and chemotherapy 55, 738-744, doi: 10.1128/AAC.00890-10 (2011).
32. Loeffler, J. M., Djurkovic, S. & Fischetti, V. A. Phage lytic enzyme Cpl-1 as a novel antimicrobial for pneumococcal bacteremia. Infection and immunity 71, 6199-6204 (2003).
33. Zhang, L. et al. LysGH15 kills Staphylococcus aureus without being affected by the humoral immune response or inducing inflammation. Sci Rep 6, 29344, doi: 10.1038/srep29344 (2016).
34. Rashel, M. et al. Efficient elimination of multidrug-resistant Staphylococcus aureus by cloned lysin derived from bacteriophage phi MR11. The Journal of infectious diseases 196, 1237-1247, doi: 10.1086/521305 (2007).
35. Gilmer, D. B., Schmitz, J. E., Euler, C. W. & Fischetti, V. A. Novel bacteriophage lysin with broad lytic activity protects against mixed infection by Streptococcus pyogenes and methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 57, 2743-2750, doi: 10.1128/AAC.02526-12 (2013).
36. Loessner, M. J., Kramer, K., Ebel, F. & Scherer, S. C-terminal domains of Listeria monocytogenes bacteriophage murein hydrolases determine specific recognition and high-affinity binding to bacterial cell wall carbohydrates. Molecular microbiology 44, 335-349 (2002).
37. Galli, S. J. The Mast Cell-IgE Paradox: From Homeostasis to Anaphylaxis. The American journal of pathology 186, 212-224, doi: 10.1016/j.ajpath.2015.07.025 (2016).
38. Urb, M. & Sheppard, D. C. The role of mast cells in the defence against pathogens. PLoS pathogens 8, e1002619, doi: 10.1371/journal.ppat.1002619 (2012).
39. Vrieze, A. et al. Impact of oral vancomycin on gut microbiota, bile acid metabolism, and insulin sensitivity. Journal of hepatology 60, 824-831, doi: 10.1016/j.jhep.2013.11.034 (2014).
40. Sonnenburg, E. D. et al. Diet-induced extinctions in the gut microbiota compound over generations. Nature 529, 212-215, doi: 10.1038/nature16504 (2016).
41. Chang, C. J. et al. Ganoderma lucidum reduces obesity in mice by modulating the composition of the gut microbiota. Nature communications 6, 7489, doi: 10.1038/ncomms8489 (2015).
42. Gu, J. et al. LysGH15, a novel bacteriophage lysin, protects a murine bacteremia model efficiently against lethal methicillin-resistant Staphylococcus aureus infection. J Clin Microbiol 49, 111-117, doi: 10.1128/JCM.01144-10 (2011).
43. Germida, J. J. & Casida, L. E. Ensifer adhaerens Predatory Activity Against Other Bacteria in Soil, as Monitored by Indirect Phage Analysis. Applied and environmental microbiology 45, 1380-1388 (1983).
44. Uchiyama, J. et al. Genetic characterization of Pseudomonas aeruginosa bacteriophage KPP10. Archives of virology 157, 733-738, doi: 10.1007/s00705-011-1210-x (2012).
45. Li, R. et al. De novo assembly of human genomes with massively parallel short read sequencing. Genome research 20, 265-272, doi: 10.1101/gr.097261.109 (2010).
46. Grant, J. R. & Stothard, P. The CGView Server: a comparative genomics tool for circular genomes. Nucleic acids research 36, W181-184, doi: 10.1093/nar/gkn179 (2008).
47. Besemer, J., Lomsadze, A. & Borodovsky, M. GeneMarkS: a self-training method for prediction of gene starts in microbial genomes. Implications for finding sequence motifs in regulatory regions. Nucleic acids research 29, 2607-2618 (2001).
48. Altschul SF1, M. T. et al. Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic acids research 25, 3389-3402 (1997).
49. Gong, P. et al. Characterization of Enterococcus faecium bacteriophage IME-EFm5 and its endolysin LysEFm5. Virology 492, 11-20, doi: 10.1016/j.virol.2016.02.006 (2016).
50. Dai, R. et al. Cloning, Expression, Purification, and Insecticidal Activity of a Novel Cry1Na3 Toxin From Bacillus thuringiensis BRC-ZYR2. Journal of economic entomology, doi: 10.1093/jee/tow031 (2016).
51. Gu, J. et al. LysGH15B, the SH3b domain of staphylococcal phage endolysin LysGH15, retains high affinity to staphylococci. Current microbiology 63, 538-542, doi: 10.1007/s00284-011-0018-y (2011).
52. Baytak, S., Zereen, F. & Arslan, Z. Preconcentration of trace elements from water samples on a minicolumn of yeast (Yamadazyma spartinae) immobilized TiO2 nanoparticles for determination by ICP-AES. Talanta 84, 319-323, doi: 10.1016/j.talanta.2011.01.020 (2011).
53. Zhao, L. et al. Structural analysis of asparaginyl endopeptidase reveals the activation mechanism and a reversible intermediate maturation stage. Cell research 24, 344-358, doi: 10.1038/cr.2014.4 (2014).
54. Gu, J. et al. A method for generation phage cocktail with great therapeutic potential. PLoS One 7, e31698, doi: 10.1371/journal.pone.0031698 (2012).
55. Xia, F. et al. Combination Therapy of LysGH15 and Apigenin as a New Strategy for Treating Pneumonia Caused by Staphylococcus aureus. Applied and environmental microbiology 82, 87-94, doi: 10.1128/AEM.02581-15 (2015).
56. Cui, Z. et al. Mannose-modified chitosan microspheres enhance OprF-OprI-mediated protection of mice against Pseudomonas aeruginosa infection via induction of mucosal immunity. Applied microbiology and biotechnology 99, 667-680, doi: 10.1007/s00253-014-6147-z (2015).
57. Evans, C. C. et al. Exercise prevents weight gain and alters the gut microbiota in a mouse model of high fat diet-induced obesity. PloS one 9, e92193, doi: 10.1371/journal.pone.0092193 (2014).
58. Magoc, T. & Salzberg, S. L. FLASH: fast length adjustment of short reads to improve genome assemblies. Bioinformatics 27, 2957-2963, doi: 10.1093/bioinformatics/btr507 (2011).
59. Bokulich, N. A. et al. Quality-filtering vastly improves diversity estimates from Illumina amplicon sequencing. Nature methods 10, 57-59, doi: 10.1038/nmeth.2276 (2013).
60. Caporaso, J. G. et al. QIIME allows analysis of high-throughput community sequencing data. Nature methods 7, 335-336, doi: 10.1038/nmeth.f.303 (2010).
61. Edgar, R. C., Haas, B. J., Clemente, J. C., Quince, C. & Knight, R. UCHIME improves sensitivity and speed of chimera detection. Bioinformatics 27, 2194-2200, doi: 10.1093/bioinformatics/btr381 (2011).
62. Haas, B. J. et al. Chimeric 16S rRNA sequence formation and detection in Sanger and 454-pyrosequenced PCR amplicons. Genome research 21, 494-504, doi: 10.1101/gr.112730.110 (2011).
63. Edgar, R. C. UPARSE: highly accurate OTU sequences from microbial amplicon reads. Nature methods 10, 996-998, doi: 10.1038/nmeth.2604 (2013).
64. Edgar, R. C. MUSCLE: multiple sequence alignment with high accuracy and high throughput. Nucleic acids research 32, 1792-1797, doi: 10.1093/nar/gkh340 (2004).